CN1312116A - Liufukang oral liquid for supporting chemotherapy and radiotherapy of terminal cancer and its preparation method - Google Patents
Liufukang oral liquid for supporting chemotherapy and radiotherapy of terminal cancer and its preparation method Download PDFInfo
- Publication number
- CN1312116A CN1312116A CN 01111427 CN01111427A CN1312116A CN 1312116 A CN1312116 A CN 1312116A CN 01111427 CN01111427 CN 01111427 CN 01111427 A CN01111427 A CN 01111427A CN 1312116 A CN1312116 A CN 1312116A
- Authority
- CN
- China
- Prior art keywords
- gram
- chemotherapy
- liufukang
- preparation
- radiotherapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a Chinese medicine Liufukang oral liquor matched with chemotherapy for curing late tumor and its preparation method. It is made from 14 Chinese medicinal materials of iron holly bark, hedyotis, bearded scutellaria, American ginseng, astragalus root, ovate atractylodes root, pinellia tuber and others through the processes of boiling by adding water to extract, filtering, heating, concentrating, regulating concentration, fine-filtering, filling, sealing and sterilizing to obtain the finished product. Said oral liquor possesses the functions of enriching supplementation and resisting cancer, increasing white blood cell, wheting appetite, obviously reducing toxic side effect of radiotherapy and chemotherapy and raising therapeutic effect.
Description
The present invention relates to a kind of Liufukang oral liquid and preparation method that cooperates chemicotherapy treatment late tumor.
Patients with advanced cancer often because of can not operation or postoperative recurrence, transfer, needs radiotherapy, chemotherapy.But some chemotherapy and conventional radiotheraphy are still unsatisfactory and toxicity is bigger at present.
The present invention is directed to above-mentioned existing problems, a kind of Liufukang oral liquid and preparation method that cooperates chemicotherapy treatment late tumor is provided, take this medicine and can play the efficacy enhancing and toxicity reducing effect, obviously alleviate the toxic and side effects of chemicotherapy.
Embodiment of the present invention be according to oncological pathology principle and the traditional Chinese medical science in clinical mainly with blood circulation promoting and blood stasis dispelling, the body resistance strengthening and constitution consolidating, hard masses softening and resolving, dispelling phlegm and eliminating dampness, heat-clearing and toxic substances removing etc. form for the main rule of treatment, and concrete scheme is that this oral liquid is made by the raw material of following consumption: Cortex Ilicis Rotundae 30-50 gram, Herba Hedyotidis Diffusae 30-50 gram, Herba Scutellariae Barbatae 30-50 gram, Radix Panacis Quinquefolii 15-30 gram, Radix Astragali 15-30 gram, Rhizoma Atractylodis Macrocephalae 12-15 gram, Rhizoma Pinelliae 10-12 gram, Rhizoma Corydalis 12-15 gram, Scorpio 0.5 gram, Fructus Toosendan 10-15 gram, Carapax Trionycis 6-10 gram, Poria 10-15 gram, Pericarpium Citri Reticulatae 10-12 gram, Radix Glycyrrhizae 6-10 gram.Method for making is: above 14 kinds of raw materials add water octuple amount and boil extraction 1 hour, filter, and filtrate is deposited in addition, and medicinal residues add six times of amounts of water again, boil and extract 1 hour, filter squeezing medicinal residues, merge extractive liquid.80 ℃ are concentrated into every milliliter and are equivalent to crude drug 0.5 gram, and standing over night use filter paper filtering, and sugaring, benzoic acid are adjusted concentration and be equivalent to crude drug 0.4 gram to every milliliter, fine straining, and embedding is sterilized, promptly in 250 milliliters of infusion bottles.
The invention has the advantages that it belongs to the nourishing anticarcinogen, the energy promoting leucocytes, stimulating appetite, compared notable difference with simple chemicotherapy, having reduced toxicity has increased the effect of chemicotherapy simultaneously, make cancer patient on base therapy, improve its survival rate, and the WBC due to the antagonism radiotherapy and chemotherapy medicine toxicity descend and the alopecia effect preferably.For performing the operation, can not accept the patient of chemicotherapy again in addition, take the effect that this medicine also has the stable state of an illness, mitigation symptoms, improves its survival rate.
Claims (1)
1, a kind of Liufukang oral liquid and preparation method that cooperates chemicotherapy treatment late tumor, it is characterized in that it is to be made by the raw material of following consumption: Cortex Ilicis Rotundae 30-50 gram, Herba Hedyotidis Diffusae 30-50 gram, Herba Scutellariae Barbatae 30-50 gram, Radix Panacis Quinquefolii 15-30 gram, Radix Astragali 15-30 gram, Rhizoma Atractylodis Macrocephalae 12-15 gram, Rhizoma Pinelliae 10-12 gram, Rhizoma Corydalis 12-15 gram, Scorpio 0.5 gram, Fructus Toosendan 10-15 gram, Carapax Trionycis 6-10 gram, Poria 10-15 gram, Pericarpium Citri Reticulatae 10-12 gram, Radix Glycyrrhizae 6-10 gram, method for making is: above 14 kinds of raw materials add water octuple amount and boil extraction 1 hour, filter, filtrate is deposited in addition, medicinal residues add six times of amounts of water again, boil and extracted 1 hour, filter, the squeezing medicinal residues, merge extractive liquid,, 80 ℃ are concentrated into every milliliter and are equivalent to crude drug 0.5 gram, standing over night is used filter paper filtering, sugaring, benzoic acid, adjustment concentration is equivalent to crude drug 0.4 to every milliliter and restrains, fine straining, sterilization, promptly.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01111427 CN1312116A (en) | 2001-03-07 | 2001-03-07 | Liufukang oral liquid for supporting chemotherapy and radiotherapy of terminal cancer and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01111427 CN1312116A (en) | 2001-03-07 | 2001-03-07 | Liufukang oral liquid for supporting chemotherapy and radiotherapy of terminal cancer and its preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1312116A true CN1312116A (en) | 2001-09-12 |
Family
ID=4659043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 01111427 Pending CN1312116A (en) | 2001-03-07 | 2001-03-07 | Liufukang oral liquid for supporting chemotherapy and radiotherapy of terminal cancer and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1312116A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102058744A (en) * | 2010-11-25 | 2011-05-18 | 代龙 | Chinese medicinal composition for treating malignant tumor and preparation method thereof |
US8173177B2 (en) | 2003-09-08 | 2012-05-08 | Genyous Biomed International Inc. | Compositions of botanical extracts for cancer therapy |
CN115990229A (en) * | 2021-11-09 | 2023-04-21 | 四川省中医药科学院 | Composition for eliminating tumor, resolving masses and/or replenishing qi to invigorate spleen |
-
2001
- 2001-03-07 CN CN 01111427 patent/CN1312116A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8173177B2 (en) | 2003-09-08 | 2012-05-08 | Genyous Biomed International Inc. | Compositions of botanical extracts for cancer therapy |
CN102058744A (en) * | 2010-11-25 | 2011-05-18 | 代龙 | Chinese medicinal composition for treating malignant tumor and preparation method thereof |
CN115990229A (en) * | 2021-11-09 | 2023-04-21 | 四川省中医药科学院 | Composition for eliminating tumor, resolving masses and/or replenishing qi to invigorate spleen |
CN115990229B (en) * | 2021-11-09 | 2024-04-12 | 四川省中医药科学院 | Composition for treating pulmonary nodules |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102512587B (en) | Decoction for treating viral myocarditis | |
CN104784347A (en) | Health-preserving medicinal liquor and manufacturing method thereof | |
CN110496157B (en) | Safflower Xiaoyao preparation for treating breast cancer and preparation method and application thereof | |
CN103182008A (en) | Preparation method for traditional Chinese medicine used for stabilizing and reducing blood pressure | |
CN1056064C (en) | Medicine for curing liver cancer and its making method | |
CN1312116A (en) | Liufukang oral liquid for supporting chemotherapy and radiotherapy of terminal cancer and its preparation method | |
CN1408383A (en) | Pure traditional Chinese medicine preparation for curing gastroinstestinal cancer and preparing method | |
CN114558074A (en) | Traditional Chinese medicine composition for treating metabolic-related fatty liver disease and preparation method and application thereof | |
CN110215485B (en) | Traditional Chinese medicine composition for treating diabetic skin ulcer and preparation method thereof | |
CN102397363A (en) | Traditional Chinese medicine for treating hypertension | |
CN110893215A (en) | Qi-tonifying and blood-nourishing medicinal liquor and preparation method thereof | |
CN1059336C (en) | Oral liquor for curing senile dementia and constipation | |
CN101278982A (en) | Chinese medicine compound preparation for curing acute or chronic hepatitis B and method of preparing the same | |
CN1772275A (en) | Medicine for treating diseases of intestine, spleen and kidney and its making process | |
CN102614420A (en) | Chinese medicine preparation for curing atrophic glossitis | |
CN103638469B (en) | A kind of Chinese medicine for the treatment of coronary heart disease | |
CN107519370B (en) | Compound preparation for treating non-allergic purpura caused by deficiency of spleen and kidney and preparation method thereof | |
CN101444616B (en) | Medicated wine for curing chronic rheumatism and method for preparing same | |
CN1070373C (en) | Medlar type health care oral liquid and preparing method thereof | |
CN107007802B (en) | Compound Chinese medicine preparation for treating leukemia caused by deficiency of both yin and yang and its preparing process | |
CN105456447A (en) | Folium artemisiae argyi-containing traditional Chinese medicine composition with function of promoting blood circulation to remove stasis and preparation method thereof | |
CN105943701A (en) | Application of medicine with functions of tonifying qi and promoting blood circulation to preparation of medicines for treating insomnia | |
CN106924483B (en) | Traditional Chinese medicine compound preparation for treating leukemia caused by spleen-kidney yang deficiency and preparation method thereof | |
CN101130039A (en) | Shenling Biochemical Oral Liquid | |
CN1123160A (en) | Chuanshentong injection and its preparation process and formula |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |